The analysis revealed a significant downregulation of KIR3DL2 in several tumor types, including lung adenocarcinoma, non-small cell lung cancer, diffuse large B-cell lymphoma, and thymoma (Figure 5A). The gene discussed is KIR3DL2; the disease is thymoma.